Adjuvant low-dose rituximab and plasma exchange for acquired TTP.

Autor: Zwicker JI; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Muia J; Department of Medicine, Washington University School of Medicine, St. Louis, MO., Dolatshahi L; Division of Pediatric Hematology, Saint Louis University School of Medicine, St. Louis, MO., Westfield LA; Department of Medicine, Washington University School of Medicine, St. Louis, MO., Nieters P; Washington University Institute of Clinical and Translational Sciences, Washington University School of Medicine, St. Louis, MO., Rodrigues A; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Hamdan A; Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Antun AG; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA., Metjian A; Division of Hematology, Duke University School of Medicine, Durham, NC; and., Sadler JE; Department of Medicine, Washington University School of Medicine, St. Louis, MO.; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO.
Jazyk: angličtina
Zdroj: Blood [Blood] 2019 Sep 26; Vol. 134 (13), pp. 1106-1109. Date of Electronic Publication: 2019 Jul 22.
DOI: 10.1182/blood.2019000795
Databáze: MEDLINE